Chinook Therapeutics, Inc. - Common Stock (NQ:KDNY)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	40.27 (1)
Ask (Size)	40.82 (1)
Prev. Close	40.39
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	66,889,369
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm

August 11, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗

August 08, 2023

Via Benzinga

Performance

More News

Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm

August 06, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Chinook Therapeutics Inc. (NASDAQ: KDNY) Highlighted for Surprising Price Action

August 01, 2023

Via Investor Brand Network

Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023 ↗

August 01, 2023

Via Benzinga

Expert Ratings for Chinook Therapeutics ↗

August 01, 2023

Via Benzinga

Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm

July 31, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm

July 26, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Chinook, Comerica, Advance Auto Parts, and EPAM and Encourages Investors to Contact the Firm

July 21, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

CHINOOK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chinook Therapeutics, Inc. - KDNY

July 21, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Chinook, Comerica, Advance Auto Parts, and EPAM and Encourages Investors to Contact the Firm

July 16, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm

July 10, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm

July 05, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Meet Chinook Therapeutics, The Company Novartis Is Spending $3.5 Billion To Acquire ↗

July 05, 2023

Via Investor's Business Daily

Bragar Eagel & Squire, P.C. Is Investigating Chinook, DLocal, Comerica, and Advanced Auto Parts and Encourages Investors to Contact the Firm

June 30, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Bowlero, Integra, Chinook, and DLocal and Encourages Investors to Contact the Firm

June 24, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Why Shares of Vera Therapeutics Jumped Tuesday ↗

June 20, 2023

Via The Motley Fool

2 Surging Healthcare Stocks With More Fuel in the Tank ↗

June 20, 2023

Via The Motley Fool

Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, Phathom, and Akumin and Encourages Investors to Contact the Firm

June 19, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review ↗

June 16, 2023

Via Investor's Business Daily

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NexTier Oilfield Solutions Inc. (NYSE – NEX), Chinook Therapeutics, Inc. (Nasdaq – KDNY), Franchise Group, Inc. (Nasdaq – FRG), Greenhill & Co., Inc. (NYSE – GHL)

June 15, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, and DZS and Encourages Investors to Contact the Firm

June 14, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 ↗

June 14, 2023

Via Benzinga

June 13, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023 ↗

June 13, 2023

Via Benzinga

Frequently Asked Questions

Is Chinook Therapeutics, Inc. - Common Stock publicly traded?

Yes, Chinook Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Chinook Therapeutics, Inc. - Common Stock trade on?

Chinook Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Chinook Therapeutics, Inc. - Common Stock?

The ticker symbol for Chinook Therapeutics, Inc. - Common Stock is KDNY on the Nasdaq Stock Market